Bispecific antibodies are following hot on the heels of CAR T-cell therapies and paving the way for more accessible and timely treatment for patients with life-limiting diseases such as cancer, as I discover in this feature for Hospital Healthcare Europe…
Photo by National Cancer Institute on Unsplash
